PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Barcelona Institute for Global Health (ISGlobal), Hospital Clínic - University of Barcelona, Rosselló 132 4rt 1a, 08036, Barcelona, Spain. berta.grau@isglobal.org.\', \'Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique. berta.grau@isglobal.org.\', \'Mundo Sano Foundation, Buenos Aires, Argentina. berta.grau@isglobal.org.\', \'Barcelona Institute for Global Health (ISGlobal), Hospital Clínic - University of Barcelona, Rosselló 132 4rt 1a, 08036, Barcelona, Spain.\', \'Infectious Diseases Department, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain.\', \'Infectious Diseases Unit, Hospital de la Santa Creu i Sant Pau - Institut d\'Investigació Biomèdica Sant Pau, 08025, Barcelona, Spain.\', \'Retrovirology and Viral Immunopathology, AIDS Research Group, IDIBAPS, Hospital Clinic, University of Barcelona, Barcelona, Spain.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1186/s13063-021-05758-9
?:doi
?:hasPublicationType
?:journal
  • Trials
is ?:pmid of
?:pmid
?:pmid
  • 34781981
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.291
?:rankingScore_hIndex
  • 57
?:title
  • Pre-exposure prophylaxis with hydroxychloroquine for COVID-19: a double-blind, placebo-controlled randomized clinical trial.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34781981>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34781981>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all